Abstract
Cardiologists caring for heart transplant recipients must be familiar with the pharmacology, drug interactions, and drug toxicity of those agents used extensively in clinical practice (cyclosporine, prednisone, azathioprine, polyclonal and monoclonal anti-T-cell agents) and the newer treatments [methotrexate, FK-506, rapamycin, mycophenolate mofetil (RS61443), deoxyspergualin, anti-CD4 monoclonal antibodies, total lymphoid irradiation, and photophoresis]. Another important aspect of medical follow-up is the detection, differential diagnosis, and treatment of allograft dysfunction. Hemodynamic abnormalities that occur as a result of rejection or a direct drug effect must be differentiated from physiologic changes. Cardiac allograft vasculopathy is the primary impediment to the long-term survival of heart transplant recipients. Immunopathogenesis, prevention, early detection, and treatment of allograft vasculopathy should be the major focus of heart transplantation research.
References
Jun 1, 1992·Mayo Clinic Proceedings·M D McGoon, R P Frantz
Aug 1, 1992·Mayo Clinic Proceedings·L J Olson, R J Rodeheffer
Sep 1, 1992·Circulation·J B O'ConnellB F Uretsky
Mar 1, 1992·Circulation·F G St GoarR L Popp
May 11, 1992·Journal of the American College of Cardiology·C M BallantyneA M Gotto
Nov 1, 1991·European Heart Journal·P A MullinsP M Schofield
Aug 1, 1991·The New England Journal of Medicine·J N CohnM Wong
Apr 1, 1990·The American Journal of Cardiology·A M KeoghJ B Hickie
Jul 1, 1990·Transplantation·B G CrandallJ B O'Connell
Nov 1, 1990·Transplantation·S L OlsenD G Renlund
Sep 13, 1990·The New England Journal of Medicine·U ScherrerR G Victor
Jun 1, 1989·Drugs·P A Todd, R N Brogden
Oct 1, 1989·Chest·K JonesJ Wallwork
Jan 1, 1989·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·D J AravotM H Yacoub
Jan 1, 1989·The American Journal of Cardiology·D J AravotM H Yacoub
Jan 1, 1989·Circulation·H A ValantineR L Popp
Aug 1, 1989·The Annals of Thoracic Surgery·D E LammermeierO H Frazier
Jun 1, 1989·Canadian Journal of Physiology and Pharmacology·B L Pope
Sep 15, 1989·The American Journal of Cardiology·P C KuoD E Vaughan
Dec 21, 1989·The New England Journal of Medicine·B D Kahan
Jun 4, 1987·The New England Journal of Medicine·UNKNOWN CONSENSUS Trial Study Group
Nov 1, 1988·The American Journal of Cardiology·S Z GaoE B Stinson
Aug 1, 1988·Journal of the American College of Cardiology·S Z GaoS A Hunt
Oct 1, 1987·Circulation·B F UretskyH T Bahnson
Jun 12, 1986·The New England Journal of Medicine·J N CohnK H Flohr
Jan 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A GreenbergJ B Puschett
Aug 1, 1971·American Journal of Surgery·R B GrieppN E Shumway
Citations
Aug 26, 1998·Journal of Cardiothoracic and Vascular Anesthesia·L M MontenegroP J Davis
Mar 17, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C BuchananF Shihab
Dec 30, 2015·North American Journal of Medical Sciences·Chetana ShenoyGururaja K Rao
Oct 24, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Leslie W Miller
Sep 18, 2020·European Heart Journal. Cardiovascular Pharmacotherapy·Seif El HadidiAndrew J S Coats